QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Panbela Therapeutics (PBLA) SEC Filings & 10K Form

$0.52
-0.02 (-2.78%)
(As of 04:22 PM ET)

Recent Panbela Therapeutics SEC Filings

DateFilerForm TypeView
04/04/2024
3:17 PM
Panbela Therapeutics (Filer)
Form DEF 14A
04/02/2024
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
03/29/2024
4:08 PM
Panbela Therapeutics (Filer)
Form POS AM
03/29/2024
4:24 PM
Panbela Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2024
3:15 PM
Panbela Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:12 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:01 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:05 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:10 PM
Lind Global Fund II LP (Filed by)
Panbela Therapeutics (Subject)
Form SC 13G/A
02/13/2024
4:24 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
6:15 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
4:28 PM
Panbela Therapeutics (Filer)
Form 424B4
01/29/2024
5:21 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2024
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
01/25/2024
11:22 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/25/2024
7:54 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/22/2024
5:08 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/19/2024
4:20 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:34 PM
Panbela Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/05/2024
11:48 AM
Panbela Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/21/2023
8:25 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
8:25 AM
Panbela Therapeutics (Filer)
Form DEFA14A
12/20/2023
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
12/21/2023
5:00 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
3:30 PM
Panbela Therapeutics (Filer)
Form DEF 14A
11/13/2023
6:27 PM
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
6:29 PM
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
4:24 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:25 PM
Panbela Therapeutics (Filer)
Form DEFA14A
09/14/2023
3:06 PM
Jacob Jeffrey E. (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
7:02 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
3:15 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:00 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:19 PM
Panbela Therapeutics (Filer)
Form 424B4
06/15/2023
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
06/02/2023
4:29 PM
Panbela Therapeutics (Filer)
Form S-1/A
05/31/2023
7:02 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2023
3:15 PM
Panbela Therapeutics (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PBLA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners